JALRA TRIO (Dapagliflozin (10mg) + Metformin (500mg) + Vildagliptin (100mg))

Jalra Trio Tablet is a therapeutic combination designed to help manage blood glucose levels. It serves as an adjunct to dietary modifications and physical activity for adults diagnosed with type 2 diabetes mellitus, aiming to enhance glycemic control. The active ingredients in this tablet facilitate the effective utilization of insulin in the body, which contributes to the reduction of blood sugar levels. It is advisable to take Jalra Trio Tablet with meals to optimize its efficacy. The prescribed dosage will be determined by your healthcare provider, and it is important not to discontinue use without medical advice. Sudden cessation of this medication can lead to increased blood sugar levels, heightening the risk of severe complications such as renal impairment and vision loss. The use of Jalra Trio Tablet should be part of a comprehensive treatment strategy, including adherence to a nutritious diet, consistent exercise, and weight management as recommended by your healthcare professional. Staying hydrated is beneficial while taking this medication, as it may help prevent dehydration. Additionally, practicing good personal hygiene can reduce the risk of fungal infections in sensitive areas. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.